Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent Rhabdoid Meningioma: Case Report.

Jeroen C Jansen1, Jenny Turner, John Sheehy

  • 1Department of ENT, Leiden University Medical Center, Leiden, The Netherlands.

Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]
|May 25, 2005
PubMed
Summary

Aggressive rhabdoid meningiomas can recur rapidly after surgery. This rare grade III subtype requires prompt, appropriate treatment due to its aggressive nature.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of the quality of life of patients with NF2-related schwannomatosis and validation of the Dutch NFTI-QOL questionnaire.

Familial cancer·2026
Same author

The Long-Term Impact of Facial Palsy on the Quality of Life of Vestibular Schwannoma Patients.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

[<sup>89</sup>Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial.

BMJ open·2026
Same author

The Effect of Allogenic Blood Transfusion on Oncologic Outcomes in Locally Advanced Kidney Cancer.

Clinical genitourinary cancer·2026
Same author

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

The Annals of otology, rhinology, and laryngology·2026
Same author

Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial.

BMJ open·2025

Area of Science:

  • Neuro-oncology
  • Pathology

Background:

  • Meningiomas are typically slow-growing tumors with low recurrence rates after subtotal resection.
  • Subtotal resection is a common surgical approach for meningioma removal.

Observation:

  • A 47-year-old woman experienced a large extracranial meningioma recurrence one year after subtotal resection.
  • Histological examination revealed an absence of typical meningioma characteristics in the recurrent tumor.

Findings:

  • Immunohistological and ultrastructural studies classified the recurrence as a grade III meningioma, rhabdoid subtype.
  • This newly recognized rhabdoid subtype exhibits aggressive behavior.

Implications:

  • Aggressive meningioma subtypes necessitate tailored treatment strategies.

Related Experiment Videos

  • Early recognition and appropriate management are crucial for patients with rhabdoid meningiomas.